Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Sanofi”

Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity CancerCompleted
NCT01536054Phase 1Updated Mar 27, 2020
Sponsor: Roswell Park Cancer Institute
Recurrent Fallopian Tube Cancer · Recurrent Ovarian Epithelial Cancer · Recurrent Primary Peritoneal Cavity Cancer · Stage IIA Fallopian Tube Cancer
United States
An Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Patients With Head and Neck Cancer Receiving REGN2810 (Anti-PD-1)Completed
NCT03198130Phase 1Updated Mar 19, 2020
Sponsor: Regeneron Pharmaceuticals
Recurrent Squamous Cell Carcinoma of Head · Recurrent Squamous Cell Carcinoma of Neck · Metastatic Squamous Cell Carcinoma of Head · Metastatic Squamous Cell Carcinoma Neck
South Korea, United Kingdom
Study to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD)Completed
NCT01979016Phase 2Updated Mar 18, 2020
Sponsor: Regeneron Pharmaceuticals
Atopic Dermatitis (AD)
United States, Canada
Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube CancerCompleted
NCT00692900Phase 1Updated Mar 12, 2020
Sponsor: University of Pittsburgh
Ovarian Cancer · Peritoneal Cancer · Fallopian Tube Cancer
United States
A Study to Confirm the Efficacy and Safety of Different Dupilumab Dose Regimens in Adults With Atopic Dermatitis (AD)Completed
NCT02395133Phase 3Updated Mar 11, 2020
Sponsor: Regeneron Pharmaceuticals
Atopic Dermatitis
Patient and Provider Assessment of Lipid Management RegistryCompleted
NCT02341664N/AUpdated Mar 2, 2020
Sponsor: Duke University
Hyperlipidemia · Hypercholesterolemia · Cardiovascular Disease · Diabetes
United States
ATG-GCSF in New Onset Type 1 DiabetesCompleted
NCT02215200Phase 2Updated Mar 2, 2020
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Diabetes Mellitus, Type 1
United States
Study of Dupilumab in Adult Participants With Active Eosinophilic Esophagitis (EoE)Completed
NCT02379052Phase 2Updated Feb 28, 2020
Sponsor: Regeneron Pharmaceuticals
Eosinophilic Esophagitis
United States
Safety and Tolerability of Dupilumab in Participants With Moderate to Severe Atopic DermatitisCompleted
NCT01385657Phase 1Updated Feb 26, 2020
Sponsor: Regeneron Pharmaceuticals
Atopic Dermatitis
Australia, Germany, New Zealand
T2007-002 Clofarabine, Etoposide, Cyclophosphamide in Relapsed Acute Myelogenous Leukemia (AML)Terminated
NCT00939653Phase 2Updated Feb 19, 2020
Sponsor: Therapeutic Advances in Childhood Leukemia Consortium
Relapsed Acute Myelogenous Leukemia
United States
NeoSAMBA: Neoadjuvant: Does the Sequence of Anthracycline and Taxane Matters: Before or After?Unknown
NCT01270373Phase 2Updated Feb 17, 2020
Sponsor: Instituto Nacional de Cancer, Brazil
Breast Cancer
Brazil
Adjuvant Aflibercept for Metastatic Colorectal CancerTerminated
NCT01669720Phase 2Updated Feb 17, 2020
Sponsor: Brown University
Metastatic Colorectal Cancer
United States
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy RegistryCompleted
NCT02554409N/AUpdated Feb 12, 2020
Sponsor: Sanofi Pasteur, a Sanofi Company
Pregnancy · Influenza
United States
Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin TherapyCompleted
NCT02421510Phase 3Updated Feb 12, 2020
Sponsor: Lexicon Pharmaceuticals
Type 1 Diabetes Mellitus
Austria, Belgium, Bulgaria, France, Germany +12 more
Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin TherapyCompleted
NCT02384941Phase 3Updated Feb 12, 2020
Sponsor: Lexicon Pharmaceuticals
Type 1 Diabetes Mellitus
United States, Canada
Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy RegistryCompleted
NCT01945424N/AUpdated Feb 12, 2020
Sponsor: Sanofi Pasteur, a Sanofi Company
Pregnancy · Influenza
United States
Safety and Efficacy of Sotagliflozin (LX4211) in Patients With Inadequately Controlled Type 1 Diabetes MellitusCompleted
NCT01742208Phase 2Updated Feb 12, 2020
Sponsor: Lexicon Pharmaceuticals
Type 1 Diabetes Mellitus
United States
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy AloneCompleted
NCT02531035Phase 3Updated Feb 12, 2020
Sponsor: Lexicon Pharmaceuticals
Type 1 Diabetes Mellitus (T1DM) · High Level of Sugar (Glucose) in the Blood
United States, Argentina, Australia, Belgium, Bulgaria +14 more
Efficacy and Safety of Sotagliflozin in Young Adult Patients With Type 1 Diabetes Mellitus and Elevated Hemoglobin A1CCompleted
NCT02383940Phase 2Updated Feb 12, 2020
Sponsor: Lexicon Pharmaceuticals
Type 1 Diabetes Mellitus
United States
Dose-ranging Study in Patients With Type 1 Diabetes MellitusCompleted
NCT02459899Phase 2Updated Feb 12, 2020
Sponsor: Lexicon Pharmaceuticals
Type 1 Diabetes Mellitus
United States
Study of the Effect of Chemotherapy With Cabazitaxel on Prostate CancerCompleted
NCT02512458Phase 2Updated Feb 10, 2020
Sponsor: Hellenic Cooperative Oncology Group
Bone Metastatic Prostate Cancer
Greece
Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ)Completed
NCT00525785Phase 2Updated Feb 10, 2020
Sponsor: M.D. Anderson Cancer Center
Stomach Cancer · Gastric Cancer
United States
Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2Completed
NCT01200485Phase 2Updated Jan 31, 2020
Sponsor: M.D. Anderson Cancer Center
Leukemia · Lymphoma
United States
Burden of Influenza at Emergency Department (ED) Level in European CountriesUnknown
NCT04244500N/AUpdated Jan 28, 2020
Sponsor: University of Rostock
Influenza, Human
Germany
Study of REGN2810 (Anti-PD-1) in Patients With Advanced MalignanciesCompleted
NCT02383212Phase 1Updated Jan 27, 2020
Sponsor: Regeneron Pharmaceuticals
Advanced Cancer · Advanced Malignancies
United States, Australia, Spain

Previous page Next page